NCT00006389View on ClinicalTrials.gov

Bryostatin 1 and Cisplatin in Treating Patients With Metastatic or Unresectable Stomach Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

October 31, 2000

Primary Completion Date

March 31, 2010

Study Completion Date

March 31, 2010

Conditions
Stage III Gastric CancerStage IV Gastric Cancer
Interventions
DRUG

bryostatin 1

Given IV

DRUG

cisplatin

Given IV

OTHER

laboratory biomarker analysis

Correlative studies

Trial Locations (1)

90033-0804

University of Southern California, Los Angeles

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00006389 - Bryostatin 1 and Cisplatin in Treating Patients With Metastatic or Unresectable Stomach Cancer | Biotech Hunter | Biotech Hunter